69 related articles for article (PubMed ID: 16778832)
1. Eriocalyxin B induces apoptosis of t(8;21) leukemia cells through NF-kappaB and MAPK signaling pathways and triggers degradation of AML1-ETO oncoprotein in a caspase-3-dependent manner.
Wang L; Zhao WL; Yan JS; Liu P; Sun HP; Zhou GB; Weng ZY; Wu WL; Weng XQ; Sun XJ; Chen Z; Sun HD; Chen SJ
Cell Death Differ; 2007 Feb; 14(2):306-17. PubMed ID: 16778832
[TBL] [Abstract][Full Text] [Related]
2. Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo.
Zhou GB; Kang H; Wang L; Gao L; Liu P; Xie J; Zhang FX; Weng XQ; Shen ZX; Chen J; Gu LJ; Yan M; Zhang DE; Chen SJ; Wang ZY; Chen Z
Blood; 2007 Apr; 109(8):3441-50. PubMed ID: 17197433
[TBL] [Abstract][Full Text] [Related]
3. The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation.
Wang L; Gural A; Sun XJ; Zhao X; Perna F; Huang G; Hatlen MA; Vu L; Liu F; Xu H; Asai T; Xu H; Deblasio T; Menendez S; Voza F; Jiang Y; Cole PA; Zhang J; Melnick A; Roeder RG; Nimer SD
Science; 2011 Aug; 333(6043):765-9. PubMed ID: 21764752
[TBL] [Abstract][Full Text] [Related]
4. Aberrant nuclear factor-kappa B activity in acute myeloid leukemia: from molecular pathogenesis to therapeutic target.
Zhou J; Ching YQ; Chng WJ
Oncotarget; 2015 Mar; 6(8):5490-500. PubMed ID: 25823927
[TBL] [Abstract][Full Text] [Related]
5. Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kappaB in human keratinocytes.
Manna SK; Sarkar S; Barr J; Wise K; Barrera EV; Jejelowo O; Rice-Ficht AC; Ramesh GT
Nano Lett; 2005 Sep; 5(9):1676-84. PubMed ID: 16159204
[TBL] [Abstract][Full Text] [Related]
6. Crystal Structures and Human Leukemia Cell Apoptosis Inducible Activities of Parthenolide Analogues Isolated from Piptocoma rufescens.
Ren Y; Gallucci JC; Li X; Chen L; Yu J; Kinghorn AD
J Nat Prod; 2018 Mar; 81(3):554-561. PubMed ID: 29350920
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of α-pinene in T-cell tumors.
Abe M; Asada N; Kimura M; Fukui C; Yamada D; Wang Z; Miyake M; Takarada T; Ono M; Aoe M; Kitamura W; Matsuda M; Moriyama T; Matsumura A; Maeda Y
Cancer Sci; 2024 Apr; 115(4):1317-1332. PubMed ID: 38279512
[TBL] [Abstract][Full Text] [Related]
8. Homoharringtonine deregulates
Chen XJ; Zhang WN; Chen B; Xi WD; Lu Y; Huang JY; Wang YY; Long J; Wu SF; Zhang YX; Wang S; Li SX; Yin T; Lu M; Xi XD; Li JM; Wang KK; Chen Z; Chen SJ
Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2220-2225. PubMed ID: 30659143
[TBL] [Abstract][Full Text] [Related]
9. A stable transcription factor complex nucleated by oligomeric AML1-ETO controls leukaemogenesis.
Sun XJ; Wang Z; Wang L; Jiang Y; Kost N; Soong TD; Chen WY; Tang Z; Nakadai T; Elemento O; Fischle W; Melnick A; Patel DJ; Nimer SD; Roeder RG
Nature; 2013 Aug; 500(7460):93-7. PubMed ID: 23812588
[TBL] [Abstract][Full Text] [Related]
10. Combination of eriocalyxin B and homoharringtonine exerts synergistic anti-tumor effects against t(8;21) AML.
Lei YC; Chen XJ; Dai YT; Dai B; Wang JY; Li MH; Liu P; Liu H; Wang KK; Jiang L; Chen B
Acta Pharmacol Sin; 2024 Mar; 45(3):633-645. PubMed ID: 38017299
[TBL] [Abstract][Full Text] [Related]
11. Protein-Nanocaged Selenium Induces t(8;21) Leukemia Cell Differentiation via Epigenetic Regulation.
Fang L; Zhang R; Shi L; Xie J; Ma L; Yang Y; Yan X; Fan K
Adv Sci (Weinh); 2023 Dec; 10(35):e2300698. PubMed ID: 37888866
[TBL] [Abstract][Full Text] [Related]
12. Eriocalyxin B alleviated ischemic cerebral injury by limiting microglia-mediated excessive neuroinflammation in mice.
Chen Y; Zhang C; Zhao L; Chen R; Zhang P; Li J; Zhang X; Zhang X
Exp Anim; 2024 Feb; 73(1):124-135. PubMed ID: 37839867
[TBL] [Abstract][Full Text] [Related]
13. Investigation of targets and anticancer mechanisms of covalently acting natural products by functional proteomics.
Zhao WS; Chen KF; Liu M; Jia XL; Huang YQ; Hao BB; Hu H; Shen XY; Yu Q; Tan MJ
Acta Pharmacol Sin; 2023 Aug; 44(8):1701-1711. PubMed ID: 36932232
[TBL] [Abstract][Full Text] [Related]
14. Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias.
Su KW; Ou DL; Fu YH; Tien HF; Hou HA; Lin LI
Cancer Gene Ther; 2022 May; 29(5):519-532. PubMed ID: 33833412
[TBL] [Abstract][Full Text] [Related]
15. Eriocalyxin B Inhibits Adipogenesis in 3T3-L1 Adipocytes by Cell Cycle Arrest.
Mu RF; Niu YF; Wang Q; Zhou HM; Hu J; Qin WY; Xiong WY
Nat Prod Bioprospect; 2020 Jun; 10(3):131-140. PubMed ID: 32314168
[TBL] [Abstract][Full Text] [Related]
16. Eriocalyxin B Induces Apoptosis and Autophagy Involving Akt/Mammalian Target of Rapamycin (mTOR) Pathway in Prostate Cancer Cells.
Yu Z; Chen Y; Liang C
Med Sci Monit; 2019 Nov; 25():8534-8543. PubMed ID: 31714902
[TBL] [Abstract][Full Text] [Related]
17. Targeting miR-193a-AML1-ETO-β-catenin axis by melatonin suppresses the self-renewal of leukaemia stem cells in leukaemia with t (8;21) translocation.
Zhou B; Ye H; Xing C; Liang B; Li H; Chen L; Huang X; Wu Y; Gao S
J Cell Mol Med; 2019 Aug; 23(8):5246-5258. PubMed ID: 31119862
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
